Teva lied about opioid role, New York says

Teva lied about opioid role, New York says


New York Attorney General Letitia James speaks during a press conference at the Office of the Attorney General in New York on May 9, 2022, to make an announcement about protecting access to abortion.

Timothy A. Clary | AFP | Getty Images

New York’s attorney general on Monday said Teva Pharmaceutical Industries lied to evade accountability for helping fuel the state’s opioid crisis, and should be restored to litigation where the Israeli company’s U.S. unit had been found liable.

In a court filing, Attorney General Letitia James said new evidence showed that a senior Teva tax executive had in a sworn affidavit made “demonstrably false” representations that the parent did not promote or sell opioids in the United States, or control Teva Pharmaceuticals USA’s finances or activities.

“This new evidence shows an even greater disregard for the pain and destruction that this company fueled,” and may constitute a “fraud on the court,” James said.

The attorney general also said Teva’s use of offshore accounts to shelter potentially large sums of money from its American business created “real concern” the company might not pay damages following a Dec. 30 Suffolk County jury verdict that the U.S. unit violated state public nuisance laws.

In a statement, Teva said: “Teva denies misleading the court, and after the court is fully briefed we expect the judge to rule in our favor.”

The company said in May it may have to pay $2.6 billion to settle U.S. opioid lawsuits nationwide.

James’ lawsuit is among more than 3,300 filed by state, local and Native American tribal governments accusing drugmakers of downplaying opioid addiction, and distributors and pharmacies of ignoring red flags about how opioids were being misused.

The attorney general said she has reached $539 million of settlements with four drugmakers, including Johnson & Johnson and Abbvie Inc, and $1.18 billion of settlements with drug distributors AmerisourceBergen, Cardinal Health and McKesson.

Teva was accused by James, Nassau County and Suffolk County of using misleading marketing for opioids, including by pushing them for off-label use.

The case focused on Teva’s generic drugs and the Actiq and Fentora cancer pain treatments. Teva’s parent company was dismissed as a defendant in December 2019.

A damages trial has yet to be held.



Source

Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.
Health

Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.

Moderna logo is seen in Warsaw, Poland on April 9, 2025. Jakub Porzycki | Nurphoto | Getty Images Moderna on Friday lowered the high end of its 2025 revenue outlook due to a delay in vaccine shipments to the U.K., but beat Wall Street’s expectations for the second quarter as it works to cut costs. […]

Read More
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
Health

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

U.S. President Donald Trump, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, David Sacks, AI & Crypto Czar and Amy Gleason, Acting Administrator, Department of Government Efficiency (DOGE) attend the “Making Health Technology Great Again” event in the East Room […]

Read More
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
Health

Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity

Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 9, 2024. Nurphoto | Nurphoto | Getty Images Eli Lilly on Thursday said its blockbuster diabetes drug Mounjaro showed heart health benefits in a late-stage trial directly comparing it to the company’s […]

Read More